181 related articles for article (PubMed ID: 35460900)
21. Food and Drug Association Approval Process for Devices Used in Endovascular Treatment of Stroke.
Gangadhara S; Siddiqui A; Mokin M
Neurology; 2021 Nov; 97(20 Suppl 2):S194-S200. PubMed ID: 34785618
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
23. What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
Yin L
J Reprod Med; 1983 Jan; 28(1):3-11. PubMed ID: 6834344
[TBL] [Abstract][Full Text] [Related]
24. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
Tylenda CA; Weintraub M
Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
[TBL] [Abstract][Full Text] [Related]
25. Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System.
Steinvil A; Rogers T; Torguson R; Waksman R
JACC Cardiovasc Interv; 2016 Sep; 9(17):1757-64. PubMed ID: 27609249
[TBL] [Abstract][Full Text] [Related]
26. Facilitating the Approval Process of Anti-Infective Technologies and Advancing Them to the Market: Insights from an FDA Workshop on Orthopaedic Device-Related Infections.
Goh GS; Tornetta P; Parvizi J
J Bone Joint Surg Am; 2021 Aug; 103(15):e57. PubMed ID: 34357892
[TBL] [Abstract][Full Text] [Related]
27. Understanding Food and Drug Administration regulatory requirements for an investigational device exemption for sponsor-investigators.
Holbein ME; Berglund JP
J Investig Med; 2012 Oct; 60(7):987-94. PubMed ID: 22847340
[TBL] [Abstract][Full Text] [Related]
28. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
[TBL] [Abstract][Full Text] [Related]
29. FDA regulation of medical devices. FDA perspective.
Burlington DB
Ann Thorac Surg; 1996 Jan; 61(1):482-4; discussion 493-8. PubMed ID: 8561634
[TBL] [Abstract][Full Text] [Related]
30. Food and Drug Administration's perspectives on pediatric cardiac assist devices.
Chen EA; Patel-Raman SM; Berman MR; Zuckerman BD
ASAIO J; 2008; 54(2):147-9. PubMed ID: 18356646
[TBL] [Abstract][Full Text] [Related]
31. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
Food and Drug Administration. HHS
Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
[TBL] [Abstract][Full Text] [Related]
32. Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP).
Manchikanti L; Centeno CJ; Atluri S; Albers SL; Shapiro S; Malanga GA; Abd-Elsayed A; Jerome M; Hirsch JA; Kaye AD; Aydin SM; Beall D; Buford D; Borg-Stein J; Buenaventura RM; Cabaret JA; Calodney AK; Candido KD; Cartier C; Latchaw R; Diwan S; Dodson E; Fausel Z; Fredericson M; Gharibo CG; Gupta M; Kaye AM; Knezevic NN; Kosanovic R; Lucas M; Manchikanti MV; Mason RA; Mautner K; Murala S; Navani A; Pampati V; Pastoriza S; Pasupuleti R; Philip C; Sanapati MR; Sand T; Shah RV; Soin A; Stemper I; Wargo BW; Hernigou P
Pain Physician; 2020 Mar; 23(2):E85-E131. PubMed ID: 32214287
[TBL] [Abstract][Full Text] [Related]
33. New technology in electrophysiology: FDA process and perspective.
Selzman KA; Fellman M; Farb A; de Del Castillo S; Zuckerman B
J Interv Card Electrophysiol; 2016 Oct; 47(1):11-18. PubMed ID: 27020440
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Data Sources That Support US Food and Drug Administration Medical Devices Safety Communications.
Tau N; Shepshelovich D
JAMA Intern Med; 2020 Nov; 180(11):1420-1426. PubMed ID: 32986074
[TBL] [Abstract][Full Text] [Related]
35. Assessment of US Food and Drug Administration-Approved Digital Medical Devices for Just-in-Time Interventions: A Systematic Review.
Phi NTT; Oikonomidi T; Ravaud P; Tran VT
JAMA Intern Med; 2023 Aug; 183(8):858-869. PubMed ID: 37459057
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiology devices and the regulatory approval process within the U.S. FDA and abroad.
Selzman KA; Patel H; Cavanaugh K
J Interv Card Electrophysiol; 2019 Nov; 56(2):173-182. PubMed ID: 31418099
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of pivotal trials and FDA review of innovative devices.
Rising JP; Moscovitch B
PLoS One; 2015; 10(2):e0117235. PubMed ID: 25651420
[TBL] [Abstract][Full Text] [Related]
38. Medical devices; medical device reporting; baseline reports. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
[TBL] [Abstract][Full Text] [Related]
39. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
[TBL] [Abstract][Full Text] [Related]
40. Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections.
Webber CM; Chen AL; Gebben DJ; Saha A; Tarver ME
Value Health; 2021 Jul; 24(7):1024-1029. PubMed ID: 34243826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
